Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 28, 2015; 21(12): 3599-3606
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3599
Figure 2
Figure 2 Cumulative disease-free survival curves of patients plotted using the Kaplan-Meier method. Green line: Cumulative disease-free survival curve of the 116 patients with TACE before LT; Blue line: Cumulative disease-free survival curve of the 88 patients without TACE before LT. The cumulative disease-free survival rates of the two groups showed a significant difference (P < 0.05, log-rank test). TACE: Transarterial chemoembolization; LT: Liver transplantation.